BPC-157 vs TB-500 — Recovery Research Compared

Both BPC-157 and TB-500 are studied in the tissue-repair and regenerative research literature. They engage different pathways and are often investigated together in published preclinical work — neither is a substitute for the other at the research-design level.

BPC-157 is a pentadecapeptide derived from human gastric juice; TB-500 is a synthetic fragment of the actin-binding protein Thymosin Beta-4. They appear together in published preclinical research because their mechanisms are complementary, not interchangeable. Peptify stocks both, plus a pre-blended 20mg Recovery vial that covers both compounds in one Janoshik Certificate of Analysis.

Both peptides in this comparison are available with full Janoshik Analytical Certificate of Analysis from Peptify UK. The page is provided for research-context and procurement-decision purposes only. All Peptify products are supplied strictly for in-vitro research use. Not for human consumption.

Browse both compounds:

• Peptify research library — full peptide-by-peptide research hubs
• How Janoshik Analytical COA testing works
• Published Certificates of Analysis

For research use only. Not for human consumption. PEPTIFY LIMITED #17021295.